Prophylactic cranial irradiation revisited: Cost-effectiveness and quality of life in small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 1, 2002, Pages 68-74

  Tai, T H Patricia ^a   Yu, Edward ^b   Dickof, Peter ^a   Beck, Glen ^c   Tonita, Jon ^a   Ago, Tete ^a   Skarsgard, David ^d   Schmidt, Marlene ^a   Schmid, Matthew ^a   Liem, John S K ^a  

^a Allan Blair Cancer Centre   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d Saskatoon Cancer Center   (Canada)

Author keywords

Cost effectiveness analysis; Prophylactic cranial irradiation; Quality of life; Radiotherapy; Small cell lung cancer

Indexed keywords

COST EFFECTIVENESS; DISEASES; IRRADIATION; PATIENT MONITORING; TOXICITY; TUMORS;

LUNG CANCER;

CELLS;

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; INTERFERON; LOMUSTINE; METHOTREXATE; MITOXANTRONE; NAVELBINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BRAIN RADIATION; CANCER STAGING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITAL COST; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RADIATION INJURY; RECURRENCE RISK; RETROSPECTIVE STUDY; THERAPY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; CRANIAL IRRADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036138258     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01748-5     Document Type: Article

References (33)

1. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer; Potential benefit restricted to patients with complete response
2. Prophylactic cranial irradiation in small cell lung cancer (SCLC) makes a comeback
3. Prophylactic cranial irradiation in limited stage small cell lung cancer; Survival benefit in patients with favourable characteristics
4. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
5. Comparative study of prophylactic cranial irradiation in patients with achieving a complete response; A long-term follow-up result
6. Treatment of small cell lung cancer; Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation
7. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
8. Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung
9. Is prophylactic cranial irradiation indicated in small-cell lung cancer?
10. Cost-effectiveness of chemotherapy; An economic evaluation of a randomized trial in small-cell lung cancer
11. Canadian cancer statistics
12. Time, dose, and fractionation in radiotherapy
13. Nonparametric estimation from incomplete observations
14. Economic evaluation of trends in cancer therapy
15. The cost of treating small cell lung cancer
16. Recommendations for reporting cost-effectiveness analysis
17. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs
18. Estimating the cost of lung cancer diagnosis and treatment in Canada; The POHEM model
19. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
20. Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer
21. Economic analysis in health care; An introduction to the methodology with an emphasis on radiation therapy
22. The Markov process in medical prognosis
23. Markov models in medical decision making; A practical guide
24. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection
25. Economic evaluation of cancer treatments; A review of the methods
26. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
27. Tamoxifen; A review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer
28. Some guidelines on the use of cost effectiveness league tables
29. The cost of radiation treatment at an Ontario regional cancer centre
30. Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer
31. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer; Results of a multicentre randomised trial